MeTC7

Description: MeTC7 is a VDR antagonist, which can be synthesized from 7-dehydrocholesterol (6) in two steps, inhibits VDR selectively, suppresses the viability of cancer cell-lines, and reduces the growth of the spontaneous transgenic TH-MYCN neuroblastoma and xenografts in vivo. Target: Others. Smiles: [H][C@@]1(CC[C@]2([H])[C@]1(C)CC[C@]1([H])[C@@]3(C)CC[C@@H](CC33C=CC21n1n3c(=O)n(C)c1=O)OC(=O)CBr)[C@H](C)CCCC(C)C